PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Direct Rx. The primary component is Pentazocine Hydrochloride; Naloxone Hydrochloride.
| Product ID | 61919-556_40f9338f-419e-19a8-e054-00144ff8d46c |
| NDC | 61919-556 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE |
| Generic Name | Pentazocine Hydrochloride And Naloxone Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-01-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075735 |
| Labeler Name | DIRECT RX |
| Substance Name | PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| Pharm Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| DEA Schedule | CIV |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2015-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA075735 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-01 |
| Ingredient | Strength |
|---|---|
| PENTAZOCINE HYDROCHLORIDE | 50 mg/1 |
| SPL SET ID: | 0967a6ed-138c-4465-9d81-fea67c00749b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43386-680 | PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | pentazocine hydrochloride and naloxone hydrochloride |
| 61919-556 | PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE |
| 0591-0395 | Pentazocine and naloxone | Pentazocine hydrochloride and naloxone hydrochloride |
| 68387-531 | Pentazocine and naloxone | PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE |